Health Tech Companies: What They Are and Who's Leading the Industry

Health tech companies are businesses that use technology software, AI, data systems, or connected devices to improve how healthcare is delivered, managed, or accessed.

They sit at the intersection of medicine and technology, and the space has grown significantly over the past decade.

What Is a Health Tech Company?

The term gets used loosely, which causes genuine confusion. A health tech company is not a hospital, not a pharmaceutical manufacturer, and not a traditional medical device maker in the old-fashioned sense.

What it is: a company that applies digital technology to a healthcare problem whether that's helping a patient book a doctor online, using AI to read a scan, or building software that helps a hospital manage billing.

What's often overlooked is how broad this category actually is. Telehealth platforms, mental health apps, genomics companies, wearable device makers, and healthcare payment software firms all sit under the same "health tech" umbrella.

That breadth is useful to understand before trying to evaluate any individual company in this space.

How is health tech different from biotech or pharma?Biotech companies primarily develop biological drugs or therapies they work at the molecular or cellular level. Pharma companies manufacture and distribute medicines.

Health tech companies, by contrast, are typically building software platforms, AI tools, or connected hardware.

Some companies blur these lines Tempus AI, for example, combines genomic data with machine learning to guide cancer treatment decisions but the core distinction holds: health tech is about the technology layer sitting on top of, or alongside, clinical care.

Major Segments Within the Health Tech Industry

Health tech is not one thing. It breaks into fairly distinct categories, each solving a different problem in the healthcare system.

Segment	What It Covers	Example Companies
Telehealth & Virtual Care	Remote consultations, online appointment booking	Zocdoc, Ro, K Health, Doctolib
AI & Data Analytics	Using data to improve diagnosis, treatment, outcomes	Tempus AI, Innovaccer, Komodo Health
Mental Health Tech	Digital therapy platforms, employer mental health benefits	Lyra Health, Spring Health, Headway
Wearables & Medical Devices	Connected health monitoring hardware	Oura, Whoop, Neuralink
Precision Medicine & Genomics	Personalised treatment based on genetic data	Caris Life Sciences, Generate Biomedicines
Health Records & Data Infrastructure	Interoperability, records management, data exchange	Datavant, PointClickCare, Particle Health
Diagnostics Technology	AI-assisted imaging, voice-based detection tools	Qure AI, Fedo, Canary Speech, Molbio Diagnostics
Digital Therapeutics & Prevention	Software-based treatment and preventive health tools	Click Therapeutics, Noom, Virta Health
Healthcare Payments & Practice Management	Billing, claims processing, financial administration	Cedar, Viz.ai, Camber

Each of these segments faces different regulatory environments, different customer bases, and different revenue models. A telehealth company sells subscriptions or per-visit fees.

A health records infrastructure company typically sells to hospital systems or payers. Knowing the segment matters when evaluating any specific company.

What Makes a Health Tech Company Worth Paying Attention To?

Funding alone is not the answer, though it's often the first metric people reach for. A company with a $5 billion valuation is not automatically more impactful than one valued at $500 million.

In this space particularly, valuation reflects investor confidence in a future outcome not current patient impact.

More useful signals include:

Regulatory clearance. For companies building diagnostic tools or digital therapeutics, FDA clearance (in the US) or equivalent approvals in other markets carry real weight.

Click Therapeutics, for example, develops prescription digital therapeutics software that is FDA-regulated as a medical treatment. That's a meaningful distinction from a wellness app.

Adoption by health systems. A product used inside major hospital networks or by large insurers has cleared a high bar.

Health systems are slow, careful buyers. If they've committed to a platform, it's been through serious evaluation.

Actual clinical evidence. Companies like Flatiron Health have built their reputation on translating real-world patient data into research that influences cancer treatment decisions. That's a different kind of credibility than a well-funded startup with a compelling pitch deck.

In practice, teams working inside health systems commonly report that the gap between a health tech product's marketing claims and its real-world performance is one of the most persistent frustrations in the sector.

Adoption is often slower than companies project, and integration with existing clinical workflows is consistently harder than expected.

Leading Health Tech Companies Globally

This is not a ranked list. Rankings in this space depend heavily on methodology TIME's 2025 analysis used financial performance, reputation, and online engagement, which measures visibility as much as impact.

What follows is a segment-by-segment overview of companies that appear consistently in industry analysis and have demonstrated meaningful scale or clinical relevance.

AI and Data Analytics Leaders

Tempus AI operates one of the largest libraries of clinical and molecular data globally, using machine learning to help physicians make more personalised treatment decisions particularly in oncology.

Qure AI has drawn attention for its deep-learning technology that analyses diagnostic imaging to detect conditions like tuberculosis and cancer, and was named among TIME's most influential companies in 2025.

Innovaccer and Komodo Health focus on aggregating and analysing population-level health data for providers and life sciences companies.

Telehealth and Virtual Care Leaders

Zocdoc is one of the more established names in this category it helps patients find and book in-network doctors online, with millions of monthly users in the US. Ro (also known as Roman Health) provides direct-to-consumer telehealth services across several condition areas.

Doctolib serves a similar function in France and parts of Europe, having raised significant capital to expand its booking and virtual care platform. WeDoctor (GuaHao) plays a comparable role in China's healthcare market.

Mental Health Tech Leaders

This segment has seen heavy investment. Lyra Health and Spring Health both offer employer-sponsored mental health benefit platforms connecting employees with therapists and coaches.

Headway has taken a different angle, building a network of therapists who accept insurance, which addresses one of the most consistent access problems in US mental healthcare.

Modern Health and Cerebral operate in similar territory, though Cerebral has faced regulatory scrutiny over prescribing practices as reported by The Wall Street Journal, which found that some clinicians at the company felt pressured to prescribe stimulants within evaluations they considered too brief to properly diagnose ADHD.

It's a reminder that regulatory risk is real and consequential in this space.

Wearables and Medical Devices

Oura produces a ring-form wearable that tracks sleep, heart rate, and other biometrics, and has expanded its health monitoring capabilities over time.

Whoop targets fitness and recovery monitoring. Neuralink, while still at an early commercial stage, is developing brain-computer interface technology it holds a valuation of around $2 billion but remains largely in the research and trial phase rather than broad deployment.

Precision Medicine and Genomics

Caris Life Sciences uses molecular profiling to help match cancer patients with targeted therapies. Generate Biomedicines applies machine learning to protein design for drug development.

These companies sit at the boundary between health tech and biotech the technology is central to what they do, but the endpoint is typically a clinical intervention.

Health Records and Data Infrastructure

Datavant focuses on connecting health data across different organisations while protecting patient privacy. PointClickCare serves the long-term and post-acute care market with its records and care management platform.

Particle Health helps healthcare innovators access and use patient medical records through a standardised API. These are less consumer-facing companies, but they form a critical layer of the digital health infrastructure.

Diagnostics Technology

Fedo uses a selfie-based tool to assess certain vital signs a striking example of AI applied to health screening. Canary Speech analyses voice patterns to detect cognitive and behavioural disorders, based on the principle that neurological changes affect speech in measurable ways.

Molbio Diagnostics, based in India, focuses on rapid molecular diagnostic testing and reached unicorn status in 2022.

Healthcare Payments and Practice Management

Cedar is building an AI-powered platform that helps patients understand and manage their medical bills addressing one of the most consistently frustrating parts of the US healthcare experience.

Viz.ai uses AI to accelerate care coordination, particularly for time-sensitive conditions like stroke. Camber focuses on streamlining claims processing for clinics, reporting a 94% first-pass rate on claims.

Where Are Health Tech Companies Based?

United States Why It Dominates

The US accounts for the majority of globally significant health tech companies, largely because of the size and complexity of the American healthcare market. Healthcare in the US is expensive, fragmented, and heavily administrative conditions that create demand for technology solutions.

The US also has a mature venture capital ecosystem that has channelled significant funding into the sector. As of early 2023, the US was home to the clear majority of health tech unicorns globally.

Europe's Growing Health Tech Hubs

France, the UK, Germany, and Sweden each have notable companies. Doctolib (France) and Alan (France) a digital health insurer are among Europe's more prominent names. CMR Surgical (UK) develops robotic surgical systems.

KRY (Sweden) provides telehealth services across several European markets. European health tech companies often operate in more regulated, publicly-funded healthcare environments, which shapes both their business models and their growth trajectories.

Asia's Key Players

China has produced several significant health tech companies, including WeDoctor (telehealth), Medlinker (chronic care), and Shukun (AI diagnostics). India's health tech sector is growing, with companies like Pristyn Care (surgical care) and Molbio Diagnostics gaining unicorn status.

Singapore hosts companies including Austrianova in precision medicine. The regulatory and infrastructure contexts across Asia vary considerably, making direct comparisons with US or European companies difficult.

How Large Is the Health Tech Market?

Precise, current figures are hard to pin down different analysts define the market differently, which leads to a wide range of estimates. What the competitor data does confirm: as of February 2023, there were at least 140 health tech unicorns (private companies valued above $1 billion) globally, with a combined valuation exceeding $320 billion.

That figure covers only private companies above the unicorn threshold it excludes publicly listed companies, acquired companies, and the broader market of smaller health tech firms.

Investment into the sector peaked around 2021. As reported by CNBC, digital health startups raised $29.1 billion that year surpassing all previous funding records as investors poured capital into remote health and virtual care themes during the pandemic.

Since then, as with broader tech markets, valuations have moderated and some companies that reached unicorn status during that period have faced pressure to demonstrate sustainable revenue.

Challenges Health Tech Companies Commonly Face

This part doesn't always make it into the glossy overviews, but it's worth understanding.

Regulatory complexity. Health tech companies operate under layers of regulation HIPAA in the US governs patient data, the FDA regulates certain digital health tools as medical devices, and international markets each have their own frameworks.

Getting a product to market in healthcare takes longer and costs more than in most other tech sectors.Healthcare system adoption.

Selling to hospitals or health systems is genuinely difficult. Procurement cycles are long, IT integration is complex, and clinical staff need to actually change workflows to use a new tool.

Many health tech companies with strong products have struggled at the adoption stage.

Data privacy. Patient data is sensitive by nature.

Companies handling health data face higher security obligations than most tech firms, and breaches carry both regulatory and reputational consequences.

Reimbursement gaps. A clinically effective digital health tool is not automatically reimbursed by insurance.

Getting a product onto a payer's covered services list is a separate challenge from getting it cleared by a regulator and many promising tools stall at this stage.

Underinvestment in prevention. As TIME's 2025 analysis noted, the prevention segment has fewer high-ranking companies than areas like AI and diagnostics.

This likely reflects a structural issue: healthcare systems, particularly in the US, reward treating illness more than preventing it, which affects where innovation capital flows.

In Summary

Health tech companies span a wide range of functions from booking a doctor's appointment to analysing genomic data for cancer treatment. The sector is large, growing, and genuinely complex.

Evaluating any company in this space requires understanding which segment it operates in, what regulatory environment it faces, and whether its impact is measured in patient outcomes or primarily in funding raised.

Frequently Asked Questions

What is the difference between health tech and biotech?

Health tech companies build digital tools software, AI, platforms, or connected devices. Biotech companies develop biological therapies at the molecular level. Some companies combine both, but the distinction usually holds.

Which health tech company has the highest valuation?

As of early 2023 data, Devoted Health held the highest private valuation among health tech unicorns at approximately $12.9 billion. Valuations shift as funding rounds occur and market conditions change.

What qualifies a company as a health tech unicorn?

A unicorn is a privately held company valued above $1 billion. It excludes publicly listed companies, acquired firms, and companies that have gone through a SPAC merger.

Is telehealth considered health tech?

Yes. Telehealth is one of the largest and most established segments within health tech, covering remote consultations, online booking, and virtual care platforms.

Are health tech companies profitable?

Many are not, particularly at early and growth stages. Most have prioritised user growth and market expansion over near-term profitability. Profitability varies significantly by segment and company maturity.